Astellas Pharma
Search results
Our office serves as the headquarters for Takeda’s Growth & Emerging Markets Business Unit, India & Southeast Asia and Taiwan, Australia & South Korea Area.
Takeda's manufacturing facility in Singapore is an integral part of the Biologics Operating Unit network with a key focus on supporting hematology products. It's also one of the leading locations for Takeda's carbon zero goals with its first-of-a-kind Zero Emissions Building.
- About Takeda Pharmaceutical Company Limited
- Media Contacts
- Important Notice
- Forward-Looking Statements
Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare G...
Vince Docherty Vince.docherty@takeda.com +65 8332-4233 Wendy Chung Wendy.chung@takeda.com +65 8321-5611 Ryoko Matsumoto ryoko.matsumoto@takeda.com +81 (0) 3-3278-3414 Christina Beckerman christina.beckerman@takeda.com +1 781-482-0831
For the purposes of this notice, “press release” means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release. This press release (including any oral briefing and any question-and-answer in connection w...
This press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include w...
- 2-ch?me-1-1 Nihonbashihonch?, Chuo City, 103-0023, Tokyo
Mar 30, 2023 · Takeda is Committed to Achieving Net Zero Greenhouse Gas Emissions in its Own Operations before 2035. Takeda (TSE:4502/NYSE:TAK) today announced the official opening of its first ‘positive energy’ manufacturing support building at its site in JTC Woodlands Industrial Park, Singapore.
Jun 26, 2024 · Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
Mar 30, 2023 · Japanese pharmaceutical giant Takeda on Thursday raised the bar for sustainability in the biotech manufacturing sector, with one of its buildings now being able to produce more renewable energy...
SINGAPORE, March 30, 2023 – Takeda (TSE:4502/NYSE:TAK) today announced the official opening of its first ‘positive energy’ manufacturing support building at its site in JTC Woodlands Industrial Park, Singapore. The site is part of the company’s global manufacturing network.
